As the Director of Business Development at G&L Healthcare Advisors, Kevin Obeirne plays a pivotal role in bridging the gap between innovative pharmaceutical and biotech companies and the complex regulatory landscape they navigate. With a robust background in regulatory affairs, Kevin leverages his expertise to...
As the Director of Business Development at G&L Healthcare Advisors, Kevin Obeirne plays a pivotal role in bridging the gap between innovative pharmaceutical and biotech companies and the complex regulatory landscape they navigate. With a robust background in regulatory affairs, Kevin leverages his expertise to guide clients through the intricacies of market entry and product approval processes. His strategic approach emphasizes a partnership model, ensuring that each client receives customized support tailored to their unique needs and objectives.
Kevin is actively involved in key projects that focus on enhancing client engagement and expanding G&L's footprint in the global regulatory landscape. His leadership in new business development initiatives has been instrumental in forging strategic alliances and fostering long-term relationships with clients across North America, Europe, and the rest of the world. By utilizing his skills in negotiation and account management, Kevin effectively communicates the value of G&L’s right-first-time approach, which is designed to minimize time-to-market and optimize compliance outcomes.
In addition to his core responsibilities, Kevin is also committed to thought leadership within the industry. He regularly participates in sponsorship and event management, contributing to discussions on regulatory trends and best practices. His proficiency in social media and media relations further enhances G&L's visibility, positioning the firm as a trusted advisor in the regulatory affairs consultancy space. With a keen understanding of drug development processes and a passion for supporting innovation, Kevin Obeirne continues to drive success for G&L Healthcare Advisors and its diverse clientele.
